Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Acuity, Froptix and eXegenics to merge to form Opko

April 2, 2007

PF-03187207 begins clinical testing for glaucoma

April 2, 2007

VEGF Trap-Eye improves retinal thickness and visual acuity in wet AMD

March 29, 2007

Jerini establishes ophthalmic subsidiary

March 23, 2007

POT-4 enters clinical development for AMD

March 21, 2007

Novel treatment strategy for glaucoma and ocular hypertension claimed by Allergan

March 15, 2007

Financing at Potentia to support AMD program

March 9, 2007

TG-100801 completes first phase I study for macular degeneration

March 2, 2007

Merck Frosst and Nippon Soda patents disclose new agents for treating eye disorders

March 2, 2007

Treatment begins in pivotal program for LX-211 in uveitis

Feb. 22, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...